agilon health (NYSE:AGL) Trading Up 5.4%

agilon health, inc. (NYSE:AGL)’s stock price traded up 5.4% during trading on Tuesday . The stock traded as high as $6.99 and last traded at $6.89. 270,091 shares changed hands during trading, a decline of 95% from the average session volume of 5,205,338 shares. The stock had previously closed at $6.54.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Truist Financial upped their target price on agilon health from $6.40 to $6.50 and gave the company a “hold” rating in a report on Friday, May 24th. Evercore ISI increased their price objective on agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a report on Tuesday, July 9th. Citigroup started coverage on agilon health in a report on Monday, April 22nd. They issued a “neutral” rating and a $6.00 price objective for the company. Stifel Nicolaus decreased their price objective on agilon health from $8.00 to $7.00 and set a “hold” rating for the company in a report on Wednesday, May 1st. Finally, Robert W. Baird started coverage on agilon health in a report on Thursday, May 30th. They issued a “neutral” rating and a $6.00 price objective for the company. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, agilon health has an average rating of “Hold” and an average target price of $9.10.

agilon health Trading Up 16.7 %

The business has a 50 day simple moving average of $6.11 and a 200-day simple moving average of $6.26. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.33 and a current ratio of 1.33. The stock has a market capitalization of $3.14 billion, a P/E ratio of -9.86 and a beta of 0.60.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.03. agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.62 billion. On average, analysts predict that agilon health, inc. will post -0.34 EPS for the current year.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently modified their holdings of AGL. Citigroup Inc. increased its position in agilon health by 242.0% during the third quarter. Citigroup Inc. now owns 26,190 shares of the company’s stock worth $465,000 after buying an additional 18,532 shares during the last quarter. Vanguard Group Inc. raised its holdings in agilon health by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 28,355,275 shares of the company’s stock worth $503,590,000 after acquiring an additional 111,487 shares during the period. Handelsinvest Investeringsforvaltning acquired a new position in agilon health during the 4th quarter worth $128,000. SG Americas Securities LLC lifted its position in agilon health by 281.0% during the 4th quarter. SG Americas Securities LLC now owns 49,101 shares of the company’s stock worth $616,000 after acquiring an additional 36,215 shares during the last quarter. Finally, Raymond James & Associates acquired a new position in agilon health during the 4th quarter worth $184,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.